Compare BBIO & SKYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBIO | SKYW |
|---|---|---|
| Founded | 2015 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.4B | 4.3B |
| IPO Year | 2019 | N/A |
| Metric | BBIO | SKYW |
|---|---|---|
| Price | $74.97 | $105.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 20 | 4 |
| Target Price | $75.75 | ★ $124.75 |
| AVG Volume (30 Days) | ★ 2.0M | 264.3K |
| Earning Date | 10-29-2025 | 01-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 78.86 |
| EPS | N/A | ★ 10.47 |
| Revenue | $353,780,000.00 | ★ $3,978,113,000.00 |
| Revenue This Year | $128.44 | $16.87 |
| Revenue Next Year | $76.14 | $3.86 |
| P/E Ratio | ★ N/A | $10.11 |
| Revenue Growth | ★ 62.46 | 19.27 |
| 52 Week Low | $25.34 | $74.70 |
| 52 Week High | $75.24 | $135.57 |
| Indicator | BBIO | SKYW |
|---|---|---|
| Relative Strength Index (RSI) | 68.19 | 60.43 |
| Support Level | $70.35 | $102.89 |
| Resistance Level | $75.10 | $104.14 |
| Average True Range (ATR) | 2.33 | 2.69 |
| MACD | -0.13 | 0.89 |
| Stochastic Oscillator | 98.77 | 76.56 |
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. Generally, SkyWest provides regional flights, and utilizes its smaller, lower-cost aircraft to carry passengers that booked tickets through airlines. It partners with carriers across the world to fly and operate aircraft for a fee. SkyWest may use the carriers's brand and ground support to coordinate marketing and easily transport passengers. The company has two reportable segments: SkyWest Airlines, which generates maximum revenue, and SkyWest Leasing.